. Henschke CI Yankelevitz DF Kostis WJ . CT screening for lung cancer . Semin Ultrasound CT MRI 2003 ; 24 : 23 – 32 . 9. Kaneko M Eguchi K Ohmatusu H . Peripheral lung cancer: screening and detection with low-dose spiral CT versus radiography
Search Results
Rebecca P. Petersen and David H. Harpole Jr.
Nishant Patel, Adam C. Yopp, and Amit G. Singal
Most patients presented initially with an abnormal imaging study, with 219 (48%) presenting with abnormal abdominal ultrasound and 149 (33%) presenting with a mass on CT or MRI. AFP level was elevated in 135 patients (30%) including 67 whose
R. Lor Randall and William Gowski
. Philadelphia, PA : Lippincott-Raven ; 1996 . 17 Colyer RA Sallay P Buckwalter K . MRI assessment of chondroid matrix tumors . In: Limb Salvage: Current Trends–Proceedings of the 7th International Symposium. Singapore: International Symposium of
Lauren E. Kernochan and Rochelle L. Garcia
Edited by Kerrin G. Robinson
tumor of the uterus: findings on sonography, CT, and gadolinium-enhanced MRI . AJR Am J Roentgenol 2008 ; 191 : 278 – 283 . 13 Zelmanowicz A Hildesheim A Sherman ME . Evidence for a common etiology for endometrial carcinomas and malignant
Lieke Gietelink, Michel W.J.M. Wouters, Pieter J. Tanis, Marion M. Deken, Martijn G. ten Berge, Rob A.E.M. Tollenaar, J. Han van Krieken, Mirre E. de Noo, and on behalf of the Dutch Surgical Colorectal Cancer Audit Group
Table 1 . A decrease occurred in unspecified clinical T classification ( P <.001). The use of MRI as preoperative imaging technique increased ( P <.001) and so did the percentage of patients who were preoperatively discussed in a multidisciplinary team
on disease stage and histology. All imaging procedures recommended in the NCCN Guidelines, including radiographs, CT scans, MRI, functional nuclear medicine imaging (PET, SPECT), and ultrasound, are included within NCCN Imaging AUC. NCCN Imaging AUC
Bishal Gyawali and Saroj Niraula
Bayesian theorem. These rates are continually estimated and updated based on the decrease in tumor volume as assessed by MRI scans. Decrease in tumor volume on MRI scans is yet to be validated as a surrogate for achieving pCR. Thus, in I-SPY 2, a correlate
expression and genome-wide copy number using gene, microRNA, and CGH arrays Assess the use of dynamic contrast-enhanced MRI in STS evaluation. Contacts: William Tap, MD • 212-639-5720 Gary Schwartz, MD • 212-639-8324 ClinicalTrials
patients with cancer by outlining all imaging procedures recommended in the NCCN Guidelines, including radiographs, CT scans, MRI, functional nuclear medicine imaging (PET, SPECT), and ultrasound. NCCN is recognized by Centers for Medicare & Medicaid
extraction on drug bioavailability. Secondary Objectives: Assess by RECIST clinical responses signals in a broad array of solid tumors. Evaluate whether dynamic contrast enhanced MRI to determine the degree of vascular permeability and PET scan to
